TABLE 3.
Model | Reference model* | Reference model + Gal-3 |
Reference model + sST2 |
[Reference model + sST2] + Gal-3 |
---|---|---|---|---|
Death | ||||
Calibration | ||||
Likelihood ratio test | - | P<0.001† | P<0.001† | P<0.001‡ |
AIC | 5951.6 | 5857.3 | 5829.0 | 5784.8 |
BIC | 5972.5 | 5882.4 | 5854.1 | 5814.1 |
Group-based calibration | P=0.009 | P=0.20 | P=0.64 | P=0.61 |
Discrimination | ||||
C-statistic (95% CI) | 0.79 (0.77–0.81) | 0.81 (0.79–0.84) | 0.82 (0.80–0.84) | 0.83 (0.81–0.85) |
Reclassification | ||||
Continuous NRI (95% CI) |
- | 0.40 (0.27–0.55) | 0.59 ( 0.50–0.66) | 0.36(0.22–0.44) |
Event NRI (95% CI) | - | 0.08 (−0.01–0.19) | 0.16 (0.10–0.23) | 0.08(−0.02–0.13) |
Nonevent NRI (95% CI) | - | 0.32 (0.28–0.40) | 0.43 (0.38–0.48) | 0.28(0.16–0.38) |
Heart failure | ||||
Calibration | ||||
Likelihood ratio test | P<0.001† | P<0.001† | P<0.001‡ | |
AIC | 4733.1 | 4703.7 | 4671.2 | 4661.1 |
BIC | 4756.6 | 4731.1 | 4698.6 | 4692.3 |
Group-based calibration | P=0.03 | P=0.31 | P=0.03 | P=0.006 |
Discrimination | ||||
C-statistic (95% CI) | 0.76 (0.74–0.79) | 0.77 (0.75–0.80) | 0.79 (0.77–0.81) | 0.80 (0.77–0.82) |
Reclassification | ||||
Continuous NRI (95% CI) |
- | 0.32 (0.20–0.40) | 0.48 ( 0.35–0.60) | 0.17 (0.09–0.27) |
Event NRI (95% CI) | - | 0.10 (0.03– 0.13) | 0.16 (0.08–0.23) | 0.02 (−0.01–0.08) |
Nonevent NRI (95% CI) | - | 0.22 (0.18–0.28) | 0.31 (0.23–0.37) | 0.14 (0.06–0.19) |
Reference model for death includes age, sex, Charlson comorbidity index and maximum troponin T. Reference model for heart failure includes age, sex, Charlson comorbidity index maximum troponin T, and heart failure prior to myocardial infarction.
Compared to reference model.
Compared to reference model + sST2.
AIC denotes Akaike information criterion; BIC, Bayesian information criterion; CI, confidence interval; Gal-3, galectin-3; NRI, net reclassification index; sST2, soluble suppression of tumorigenicity-2.